Publikationen von Klaus-Armin Nave
Alle Typen
Zeitschriftenartikel (357)
301.
Zeitschriftenartikel
158 (4), S. 709 - 718 (2002)
Notch1 control of oligodendrocyte differentiation in the spinal cord. Journal of Cell Biology 302.
Zeitschriftenartikel
20 (1), S. 93 - 109 (2002)
Identification of the Regulatory Region of the Peripheral Myelin Protein 22 (PMP22) Gene That Directs Temporal and Spatial Expression in Development and Regeneration of Peripheral Nerves. Molecular and Cellular Neuroscience 303.
Zeitschriftenartikel
157 (2), S. 327 - 336 (2002)
Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/lysosomes: implications for Pelizaeus-Merzbacher disease. The Journal of Cell Biology: JCB 304.
Zeitschriftenartikel
125 (3), S. 551 - 561 (2002)
Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 305.
Zeitschriftenartikel
67 (4), S. 443 - 449 (2002)
Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1A. Journal of Neuroscience Research 306.
Zeitschriftenartikel
28 (1), S. 75 - 78 (2002)
Observations on the structure of myelin lacking the major proteolipid protein. Neuropathology and Applied Neurobiology 307.
Zeitschriftenartikel
18 (6), S. 593 - 605 (2001)
Multiple Splice Isoforms of Proteolipid M6B in Neurons and Oligodendrocytes. Molecular and Cellular Neuroscience 308.
Zeitschriftenartikel
30 (9-10), S. 841 - 855 (2001)
Differential expression of apoptotic markers in jimpy and in Plp overexpressors: evidence for different apoptotic pathways. Journal of Neurocytology 309.
Zeitschriftenartikel
50 (1), S. 47 - 55 (2001)
PMP22 transgenic dorsal root ganglia cultures show myelin abnormalities similar to those of human CMT1A. Annals of Neurology 310.
Zeitschriftenartikel
26, S. 639 - 645 (2001)
Mutant PLP/DM20 Cannot Be Processed to Secrete PLP-Related Oligodendrocyte Differentiation/Survival Factor. Neurochemical Research 311.
Zeitschriftenartikel
52 (6), S. 656 - 671 (2001)
Membrane traffic in myelinating oligodendrocytes. Microscopy Research and Technique 312.
Zeitschriftenartikel
21 (3), S. 920 - 933 (2001)
The AN2 Protein Is a Novel Marker for the Schwann Cell Lineage Expressed by Immature and Nonmyelinating Schwann Cells. The Journal of Neuroscience 313.
Zeitschriftenartikel
63 (2), S. 151 - 164 (2001)
Myelin proteolipid proteins promote the interaction of oligodendrocytes and axons. Journal of Neuroscience Research 314.
Zeitschriftenartikel
15, S. 66 - 78 (2001)
The transcription factor Sox10 is a key regulator of peripheral glial development. Genes and Development 315.
Zeitschriftenartikel
20 (11), S. 4120 - 4128 (2000)
Uncoupling of Myelin Assembly and Schwann Cell Differentiation by Transgenic Overexpression of Peripheral Myelin Protein 22. The Journal of Neuroscience 316.
Zeitschriftenartikel
20 (10), S. 3714 - 3724 (2000)
Neuronal Basic Helix-Loop-Helix Proteins (NEX and BETA2/Neuro D) Regulate Terminal Granule Cell Differentiation in the Hippocampus. The Journal of Neuroscience 317.
Zeitschriftenartikel
6, S. 56 - 61 (2000)
Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nature Medicine 318.
Zeitschriftenartikel
883 (1), S. 234 - 246 (1999)
Distinct Phenotypes Associated with Increasing Dosage of the PLP Gene: Implications for CMT1A Due toPMP22Gene Duplication. Annals of the New York Academy of Sciences 319.
Zeitschriftenartikel
883 (1), S. 254 - 261 (1999)
The “CMT Rat”: Peripheral Neuropathy and Dysmyelination Caused by Transgenic Overexpression ofPMP22. Annals of the New York Academy of Sciences 320.
Zeitschriftenartikel
883 (1), S. 247 - 253 (1999)
Transgenic Mouse Models of CMT1A and HNPP. Annals of the New York Academy of Sciences